SMILESynergy: Anticancer drug synergy prediction based on Transformer pre-trained model.
10.7507/1001-5515.202209043
- Author:
Liqiang ZHANG
1
;
Yufang QIN
1
;
Ming CHEN
1
Author Information
1. College of Information, Shanghai Ocean University, Shanghai 201306, P. R. China.
- Publication Type:Journal Article
- Keywords:
Attention;
Deep learning;
Synergy;
Transformer
- MeSH:
Electric Power Supplies;
Neural Networks, Computer;
Antineoplastic Agents/pharmacology*
- From:
Journal of Biomedical Engineering
2023;40(3):544-551
- CountryChina
- Language:Chinese
-
Abstract:
The synergistic effect of drug combinations can solve the problem of acquired resistance to single drug therapy and has great potential for the treatment of complex diseases such as cancer. In this study, to explore the impact of interactions between different drug molecules on the effect of anticancer drugs, we proposed a Transformer-based deep learning prediction model-SMILESynergy. First, the drug text data-simplified molecular input line entry system (SMILES) were used to represent the drug molecules, and drug molecule isomers were generated through SMILES Enumeration for data augmentation. Then, the attention mechanism in the Transformer was used to encode and decode the drug molecules after data augmentation, and finally, a multi-layer perceptron (MLP) was connected to obtain the synergy value of the drugs. Experimental results showed that our model had a mean squared error of 51.34 in regression analysis, an accuracy of 0.97 in classification analysis, and better predictive performance than the DeepSynergy and MulinputSynergy models. SMILESynergy offers improved predictive performance to assist researchers in rapidly screening optimal drug combinations to improve cancer treatment outcomes.
